Read More Analyst Ratings Initiation News Price Target HC Wainwright & Co. Assumes Aprea Therapeutics at Buy, Announces Price Target of $3 By Benzinga Newsdesk Today, 7:46 PM HC Wainwright & Co. analyst Joseph Pantginis assumes Aprea Therapeutics (NASDAQ:APRE) with a Buy rating and announces Price Target of $3. APRE
Read More Dividends Earnings News $100 Invested In Chubb 20 Years Ago Would Be Worth This Much Today By Benzinga Insights Today, 7:46 PM Chubb (NYSE:CB) has outperformed the market over the past 20 years by 2.11% on an annualized basis producing an average annual return of 9.97%. Currently, Chubb has a market capitalization of $82.67 billion. CB
Read More News ‘Ford Developing All-New EV On All-New Full-Size Pickup Platform’ -InsideEVs By Benzinga Newsdesk Today, 7:46 PM https://insideevs.com/news/552740/ford-new-fullsize-pickup-platform/amp/ F
Read More Analyst Ratings News Price Target Morgan Stanley Maintains Underweight on Roku, Lowers Price Target to $55 By Benzinga Newsdesk Today, 7:46 PM Morgan Stanley analyst Benjamin Swinburne maintains Roku (NASDAQ:ROKU) with a Underweight and lowers the price target from $80 to $55. ROKU